These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 28683284)

  • 1. Is Type 2 Diabetes a Glycogen Storage Disease of Pancreatic β Cells?
    Ashcroft FM; Rohm M; Clark A; Brereton MF
    Cell Metab; 2017 Jul; 26(1):17-23. PubMed ID: 28683284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperglycaemia induces metabolic dysfunction and glycogen accumulation in pancreatic β-cells.
    Brereton MF; Rohm M; Shimomura K; Holland C; Tornovsky-Babeay S; Dadon D; Iberl M; Chibalina MV; Lee S; Glaser B; Dor Y; Rorsman P; Clark A; Ashcroft FM
    Nat Commun; 2016 Nov; 7():13496. PubMed ID: 27882918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic β cells: Gatekeepers of type 2 diabetes.
    Park YJ; Woo M
    J Cell Biol; 2019 Apr; 218(4):1094-1095. PubMed ID: 30696700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial myopathy, Fanconi syndrome with impaired glycogen and galactose metabolism.
    Hurvitz H; Kerem E; Elpeleg ON; Barash V; Klar A; Mor C; Branski D
    Prog Clin Biol Res; 1989; 306():143-8. PubMed ID: 2740408
    [No Abstract]   [Full Text] [Related]  

  • 5. Specific reduction of hepatic glucose 6-phosphate transporter-1 ameliorates diabetes while avoiding complications of glycogen storage disease.
    Sloop KW; Showalter AD; Cox AL; Cao JX; Siesky AM; Zhang HY; Irizarry AR; Murray SF; Booten SL; Finger EA; McKay RA; Monia BP; Bhanot S; Michael MD
    J Biol Chem; 2007 Jun; 282(26):19113-21. PubMed ID: 17478431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic models rule out a major role of beta cell glycogen in the control of glucose homeostasis.
    Mir-Coll J; Duran J; Slebe F; García-Rocha M; Gomis R; Gasa R; Guinovart JJ
    Diabetologia; 2016 May; 59(5):1012-20. PubMed ID: 26825527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pancreatic beta-cell in human Type 2 diabetes.
    Marchetti P; Del Prato S; Lupi R; Del Guerra S
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16 Suppl 1():S3-6. PubMed ID: 16530127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance versus beta-cell dysfunction in the pathogenesis of type 2 diabetes.
    Ferrannini E
    Curr Diab Rep; 2009 Jun; 9(3):188-9. PubMed ID: 19490819
    [No Abstract]   [Full Text] [Related]  

  • 9. Transcription factor Ets-1 links glucotoxicity to pancreatic beta cell dysfunction through inhibiting PDX-1 expression in rodent models.
    Chen F; Sha M; Wang Y; Wu T; Shan W; Liu J; Zhou W; Zhu Y; Sun Y; Shi Y; Bleich D; Han X
    Diabetologia; 2016 Feb; 59(2):316-24. PubMed ID: 26564177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and clinical aspects of glycogen storage diseases.
    Ellingwood SS; Cheng A
    J Endocrinol; 2018 Sep; 238(3):R131-R141. PubMed ID: 29875163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of β-Cell Hypoxia in the Progression of Type 2 Diabetes.
    Yamagata K; Tsuyama T; Sato Y
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol in beta-cell dysfunction: the emerging connection between HDL cholesterol and type 2 diabetes.
    Brunham LR; Kruit JK; Hayden MR; Verchere CB
    Curr Diab Rep; 2010 Feb; 10(1):55-60. PubMed ID: 20425068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen storage disease as a unifying mechanism of disease in the PRKAG2 cardiac syndrome.
    Gollob MH
    Biochem Soc Trans; 2003 Feb; 31(Pt 1):228-31. PubMed ID: 12546691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rac1-NADPH oxidase signaling promotes CD36 activation under glucotoxic conditions in pancreatic beta cells.
    Elumalai S; Karunakaran U; Lee IK; Moon JS; Won KC
    Redox Biol; 2017 Apr; 11():126-134. PubMed ID: 27912197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
    Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
    Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethyl acetate fraction of Aframomum melegueta fruit ameliorates pancreatic β-cell dysfunction and major diabetes-related parameters in a type 2 diabetes model of rats.
    Mohammed A; Koorbanally NA; Islam MS
    J Ethnopharmacol; 2015 Dec; 175():518-27. PubMed ID: 26456345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin Resistance and Diabetes Mellitus in Alzheimer's Disease.
    Burillo J; Marqués P; Jiménez B; González-Blanco C; Benito M; Guillén C
    Cells; 2021 May; 10(5):. PubMed ID: 34069890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial glycogen dynamics: new perspectives on disease mechanisms.
    Chandramouli C; Varma U; Stevens EM; Xiao RP; Stapleton DI; Mellor KM; Delbridge LM
    Clin Exp Pharmacol Physiol; 2015 Apr; 42(4):415-25. PubMed ID: 25676548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of type 2 diabetes and importance of vitamin D3-vitamin D receptor interaction in pancreatic β-cells.
    Neelankal John A; Jiang FX
    J Diabetes Complications; 2018 Apr; 32(4):429-443. PubMed ID: 29422234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.